🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Obstacle Course Versus Neuromotor Task Training in Children With DCD

RecruitingNAAges 7 Years - 10 YearsAllRiphah International University
NCT07575178 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Developmental Coordination Disorder (DCD) affects motor planning and functional mobility in children, leading to long-term functional and psychosocial difficulties. This randomized clinical trial will compare the effectiveness of Obstacle Course Training (OCT) and Neuromotor Task Training (NTT) in improving motor planning and functional mobility in children aged 7-10 years diagnosed with DCD. Participants will be randomly allocated to either OCT or NTT for 9 weeks (two sessions per week). Outcomes will be assessed using standardized motor performance measures to determine the more effective intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Diagnosis of DCD based on DSM4/5 criteria. * Children aged 7-10. * Gender male and female. * Mini-Mental State Examination (MMSE) score \>24 . * Cognitive development appropriate for chronological age. * Raven Intelligence Test Scale (IQ \> 75) . * Developmental Coordination Questionnaire ≤48 points: likely DCD (≤ 10th percentile). * BOT-2 score ≤ 40. Exclusion Criteria: * History of surgery and lower limb injuries over the past 12 months. * Use of assistive devices to balance and walk. * Severe ADHD, Autism Spectrum Disorder (if it significantly interferes with participation), or major psychiatric disorders. * Taking neuroleptics or any other medications that significantly alter muscle tone, coordination, or attention.
💊

What it tests

  • Obstacle Course Training
  • Neuromotor Task Training
📍

Where

2 sites
Riphah Rehabilitation Center, Riphah International University
Lahore, Pakistan
University Of Lahore Teaching Hospital ULTH
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy